Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression

por Bachawal, Sunitha, Bean, Gregory R., Krings, Gregor, Wilson, Katheryne E.
Publicado 2020

Synchronous Breast Implant–associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications

por Mukhtar, Rita A., Holland, Michael, Sieber, David A., Wen, Kwun Wah, Rugo, Hope S., Kadin, Marshall E., Bean, Gregory R.
Publicado 2019

Correction to: Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast

por Bean, Gregory R., Najjar, Saleh, Shin, Sandra J., Hosfield, Elizabeth M., Caswell-Jin, Jennifer L., Urisman, Anatoly, Jones, Kirk D., Chen, Yunn-Yi, Krings, Gregor
Publicado 2022

Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast

por Bean, Gregory R., Najjar, Saleh, Shin, Sandra J., Hosfield, Elizabeth M., Caswell-Jin, Jennifer L., Urisman, Anatoly, Jones, Kirk D., Chen, Yunn-Yi, Krings, Gregor
Publicado 2022

Transcriptional and Immune Landscape of Cardiac Sarcoidosis

por Liu, Jing, Ma, Pan, Lai, Lulu, Villanueva, Ana, Koenig, Andrew, Bean, Gregory R., Bowles, Dawn E., Glass, Carolyn, Watson, Michael, Lavine, Kory J., Lin, Chieh-Yu
Publicado 2022

The Interaction of SWI/SNF with the Ribosome Regulates Translation and Confers Sensitivity to Translation Pathway Inhibitors in Cancers with Complex Perturbations

por Ulicna, Livia, Kimmey, Samuel C., Weber, Christopher M., Allard, Grace M., Wang, Aihui, Bui, Nam Q., Bendall, Sean C., Crabtree, Gerald R., Bean, Gregory R., Van Rechem, Capucine
Publicado 2022

A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas

por Bean, Gregory R, Kremer, Jeff C, Prudner, Bethany C, Schenone, Aaron D, Yao, Juo-Chin, Schultze, Matthew B, Chen, David Y, Tanas, Munir R, Adkins, Douglas R, Bomalaski, John, Rubin, Brian P, Michel, Loren S, Van Tine, Brian A
Publicado 2016

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

por Hurvitz, Sara A., Caswell-Jin, Jennifer L., McNamara, Katherine L., Zoeller, Jason J., Bean, Gregory R., Dichmann, Robert, Perez, Alejandra, Patel, Ravindranath, Zehngebot, Lee, Allen, Heather, Bosserman, Linda, DiCarlo, Brian, Kennedy, April, Giuliano, Armando, Calfa, Carmen, Molthrop, David, Mani, Aruna, Chen, Hsiao-Wang, Dering, Judy, Adams, Brad, Kotler, Eran, Press, Michael F., Brugge, Joan S., Curtis, Christina, Slamon, Dennis J.
Publicado 2020